The NDIA has released the Annual Pricing Review (APR) Report. The Report provides guidance on what the Agency considers appropriate NDIS prices for 2026-27.
This year the NDIA used a larger set of data to compare therapy support pricing. This included more than 16 million therapy transactions from private health insurance and similar government schemes. This is about 5 million more than last year.
This additional data helped the NDIA develop the evidence-based recommendations in this year’s review.
To support participants and providers, the NDIA has also released the NDIS Pricing Schedule. This document gives guidance on appropriate prices for NDIS supports, including those from the APR.
From 1 July 2026, providers can use the NDIS Pricing Schedule to inform their prices. Providers must discuss proposed changes to existing service agreements with participants and participants must agree to the changes.
On 14 May 2026, the National Disability Insurance Scheme Amendment (Securing the NDIS for Future Generations) Bill 2026 (Bill) was introduced into Parliament. The Bill proposes to provide the Minister for the NDIS with the power to make a pricing determination.
This year’s APR sets out guidance and views regarding appropriate NDIS prices. If the Bill is subsequently passed, it is anticipated that the APR will inform any advice provided by the NDIA to the Minister for the NDIS on pricing.
Read the full Annual Pricing Review.